Utility and Safety of Commercially Available Injection Laryngoplasty Materials in a Rabbit Model
- Authors
- Moon, Il Ha; Park, Ki Nam; Kim, Hee Kyung; Lee, SeungWon
- Issue Date
- Jan-2015
- Publisher
- Mosby Inc.
- Keywords
- Injection laryngoplasty; Vocal fold; Foreign body
- Citation
- Journal of Voice, v.29, no.1
- Journal Title
- Journal of Voice
- Volume
- 29
- Number
- 1
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10994
- DOI
- 10.1016/j.jvoice.2014.06.008
- ISSN
- 0892-1997
1873-4588
- Abstract
- Objective. To demonstrate foreign body and chronic inflammatory reaction of commercially available injection materials using the rabbit vocal fold paralysis model. Study Design. Animal study. Methods. The left recurrent laryngeal nerve was identified and divided at the tracheoesophageal groove. Amounts (100 mu L) of phosphate-buffered saline (PBS), polyacrylamide hydrogel (Aquamid; Ferrosan A/S, Soborg, Denmark), calcium hydroxyapatite (Radiesse; BioForm Medical Inc., San Mateo, CA), or hyaluronic acid derivative (Rofilan; Rofil Medical International, Breda, Netherlands) were injected into the left vocalis muscle. Six months later, the larynx was harvested. Hematoxylin/eosin and Masson trichrome staining were performed to compare inflammatory and foreign body reactions, granuloma development, and relative vocal fold areas among groups. Results. Compared with the PBS (control) group, the Aquamid, Radiesse, and Rofilan groups exhibited only mild chronic inflammatory reactions that did not significantly differ among groups, or from controls (P > 0.05). However, the Aquamid and Radiesse groups exhibited moderate foreign body reactions that were significantly greater than those of controls (P < 0.05). No foreign body granuloma formed in any group. All test groups exhibited significant increases in vocal fold areas at 6 months (P < 0.05). Conclusions. Although commercially available injection materials induced more foreign body reactions than a control injection of PBS, no foreign body granuloma developed and the augmented vocal fold area was maintained until 6 months after injection.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Pathology > 1. Journal Articles
- College of Medicine > Department of Otorhinolaryngology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10994)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.